[
  {
    "ts": "2025-11-29T03:09:29+00:00",
    "headline": "Why Analysts See the Story Changing for Armstrong World Industries After Fresh Upgrades and Growth Signals",
    "summary": "Armstrong World Industries stock has seen its fair value remain steady at $207.1 as a slight decrease in the discount rate occurs. These subtle shifts come as analysts cite strengthened confidence in the company’s growth outlook, following positive revisions in market sentiment and anticipated expansion in key markets. Read on to discover how you can stay informed on future narrative shifts impacting Armstrong’s outlook. Stay updated as the Fair Value for Armstrong World Industries shifts by...",
    "url": "https://finance.yahoo.com/news/why-analysts-see-story-changing-030929976.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "75dedfa1-c306-3260-b46e-46bd1f0ef65b",
      "content": {
        "id": "75dedfa1-c306-3260-b46e-46bd1f0ef65b",
        "contentType": "STORY",
        "title": "Why Analysts See the Story Changing for Armstrong World Industries After Fresh Upgrades and Growth Signals",
        "description": "",
        "summary": "Armstrong World Industries stock has seen its fair value remain steady at $207.1 as a slight decrease in the discount rate occurs. These subtle shifts come as analysts cite strengthened confidence in the company’s growth outlook, following positive revisions in market sentiment and anticipated expansion in key markets. Read on to discover how you can stay informed on future narrative shifts impacting Armstrong’s outlook. Stay updated as the Fair Value for Armstrong World Industries shifts by...",
        "pubDate": "2025-11-29T03:09:29Z",
        "displayTime": "2025-11-29T03:09:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/51f3305c1122cc0aece72cb5d1045e9b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m5G0aQzDhv06uhuE4nB35w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/51f3305c1122cc0aece72cb5d1045e9b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VELrIe8oU5L64jJlewX.Ag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/51f3305c1122cc0aece72cb5d1045e9b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-story-changing-030929976.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-story-changing-030929976.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AWI"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-29T11:05:22+00:00",
    "headline": "What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism",
    "summary": "Boston Scientific stock remains under close watch as the company's fair value target holds steady at $126.48 per share. This reflects analysts' continued confidence following the latest results. While the discount rate saw only a marginal shift, most analysts have reaffirmed or raised their price targets, driven by the company's robust performance and positive outlook. Stay tuned to learn the best ways to monitor the evolving narrative and outlook for Boston Scientific as market conditions...",
    "url": "https://finance.yahoo.com/news/could-shift-story-boston-scientific-110522869.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "fd08622b-638b-39e9-8d51-7b49ad88c8bd",
      "content": {
        "id": "fd08622b-638b-39e9-8d51-7b49ad88c8bd",
        "contentType": "STORY",
        "title": "What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism",
        "description": "",
        "summary": "Boston Scientific stock remains under close watch as the company's fair value target holds steady at $126.48 per share. This reflects analysts' continued confidence following the latest results. While the discount rate saw only a marginal shift, most analysts have reaffirmed or raised their price targets, driven by the company's robust performance and positive outlook. Stay tuned to learn the best ways to monitor the evolving narrative and outlook for Boston Scientific as market conditions...",
        "pubDate": "2025-11-29T11:05:22Z",
        "displayTime": "2025-11-29T11:05:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/could-shift-story-boston-scientific-110522869.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/could-shift-story-boston-scientific-110522869.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]